— Know what they know.
Not Investment Advice

AMRN NASDAQ

Amarin Corporation plc
1W: -6.4% 1M: -9.8% 3M: -21.5% YTD: -10.0% 1Y: -25.8% 3Y: -32.6% 5Y: -88.6%
$12.35
-0.37 (-2.91%)
 
Weekly Expected Move ±3.9%
$11 $12 $12 $13 $13
NASDAQ · Healthcare · Drug Manufacturers - General · Tech Score Strong Sell · Power 28 · $255.4M mcap · 21M float · 0.359% daily turnover · Short 38% of daily vol

Supply Chain Overview

1 relationships
1
As Filer
counterparties named
0
As Counterparty
mentioned by others
1
Rel. Types
2025-06-24
Earliest Filing
2025-06-24
Latest Filing
partner: 1

Counterparties (Filed by AMRN)

1 relationships

Companies named in AMRN's SEC 8-K filings as business counterparties.

Counterparty Ticker Relationship Summary Filing Date SEC
Recordati Industria Chimica e Farmaceutica S.p.A. — partner Entered into an exclusive long-term license and supply agreement to develop and commercialize VAZKEPA® in Europe. 2025-06-24 View
Recent 8-K Filings (20)
Filing Date Description Type SEC
2026-07-29 Earnings Release; Exhibits View
2026-05-15 Shareholder Vote View
2026-04-29 Earnings Release; Exhibits View
2026-03-27 Officer/Director Change; Exhibits View
2026-02-25 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2026-01-08 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2025-10-29 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2025-10-22 Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits View
2025-07-30 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2025-07-03 Departure/Election of Directors; Appointment of Officers View
2025-06-24 Entry into Material Definitive Agreement; Costs Associated with Exit or Disposal Activities; Regulat Agreement View
2025-05-15 Submission of Matters to a Vote of Security Holders View
2025-05-07 Results of Operations and Financial Condition; Financial Statements and Exhibits View
2025-04-29 Notice of Delisting or Transfer; Regulation FD Disclosure; Financial Statements and Exhibits View
2025-04-09 Material Modification to Rights of Security Holders; Regulation FD Disclosure; Financial Statements View
2025-04-07 Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits View
2025-03-28 Departure/Election of Directors; Appointment of Officers View
2025-03-12 Results of Operations and Financial Condition; Material Modification to Rights of Security Holders; View
2024-12-18 Departure/Election of Directors; Appointment of Officers View
2024-11-22 Notice of Delisting or Transfer View
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text. Covers 2021–2026. View on SEC EDGAR

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms